Michael D Henry (Michael Henry)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Basal Cell Carcinoma

Circulating Tumor

Top Venues

bioRxiv : the preprint server for biology

Molecular & cellular oncology

Disease models & mechanisms

University of Iowa College of Medicine

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Iowa College of Medicine

United States

Professor :: Molecular Physiology and Biophysics

Millennium Pharmaceuticals Inc

United States

Sr. Scientist :: Cancer Pharmacology

Education History

Massachusetts Institute of Technology

United States

PHD :: Biology

University of Georgia

United States

BSC :: Genetics

Publications

Mary E Herndon, Mitchell Ayers, Katherine Gibson-Corley, Michael K Wendt, Lori L Wallrath, Michael D Henry, Christopher S Stipp
The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial-mesenchymal phenotype. Disease models & mechanisms (2024)
Jeremy Chang, Katelyn R Campbell-Hanson, Marion Vanneste, Julius Yevdash, Nicholas I Bartschat, Jiarui Jiang, Ardith Bhinu, Annika Helverson, Michael D Henry, Eirikur Steingrimsson, Ronald J Weigel, Robert A Cornell, Colin P Kenny
An MITF- and mTOR-dependent FLCN pathway suppresses TFE3-driven metastasis in melanoma. bioRxiv : the preprint server for biology (2024)
Jeremy Chang, Katelyn R Campbell-Hanson, Marion Vanneste, Julius Yevdash, Nicholas I Bartschat, Jiang Jiarui, Ardith Bhinu, Annika Helverson, Michael D Henry, Eirikur Steingrimsson, Ronald J Weigel, Robert Cornell, Colin P Kenny
An MITF- and mTOR-dependent FLCN pathway suppresses TFE3-driven metastasis in melanoma. bioRxiv : the preprint server for biology (2024)
Devon L Moose, Michael D Henry
Survival of the resilient: Mechano-adaptation of circulating tumor cells to fluid shear stress. Molecular & cellular oncology 7 (4) (2020)